EP 4106732 A1 20221228 - PHARMACEUTICAL COMPOSITION COMPRISING DAPAGLIFLOZIN
Title (en)
PHARMACEUTICAL COMPOSITION COMPRISING DAPAGLIFLOZIN
Title (de)
PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT DAPAGLIFLOZIN
Title (fr)
COMPOSITION PHARMACEUTIQUE COMPRENANT DE LA DAPAGLIFLOZINE
Publication
Application
Priority
- EP 20460013 A 20200221
- EP 2021053880 W 20210217
Abstract (en)
[origin: WO2021165316A1] The present invention relates to a dapagliflozin granulate composition, which is suitable for preparing capsules or tablets. It also relates to a pharmaceutical dosage form for oral administration which comprises such granulate. The invention also relates to a method for the preparation of the dapagliflozin granulate and to the use of the dosage forms containing it for the treatment of diabetes mellitus.
IPC 8 full level
A61K 9/16 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01); A61K 31/155 (2006.01); A61K 31/70 (2006.01); A61P 5/50 (2006.01)
CPC (source: EP)
A61K 9/1611 (2013.01); A61K 9/1652 (2013.01); A61K 9/2054 (2013.01); A61K 9/4866 (2013.01); A61K 31/70 (2013.01); A61P 5/50 (2017.12)
Citation (search report)
See references of WO 2021165316A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2021165316 A1 20210826; CA 3169665 A1 20210826; EP 4106732 A1 20221228
DOCDB simple family (application)
EP 2021053880 W 20210217; CA 3169665 A 20210217; EP 21705529 A 20210217